Stagezero Life Sciences (PK) Stock Price - GNWSF

-0.002 (-3.85%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Stagezero Life Sciences Ltd (PK) GNWSF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.002 -3.85% 0.05 0.05 0.0567 0.055 0.052 16:30:02
Bid Price Ask Price Spread Spread % News
0.048 0.0792 0.0312 39.39% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
10 45,400 $ 0.050629 $ 2,299 33,243 0.0218 - 0.145
Last Trade Time Type Quantity Stock Price Currency
15:07:31 1,000 $ 0.05 USD

Stagezero Life Sciences (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 15.89M 317.74M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
91.40k $ - 0.00% - -

more financials information »

Stagezero Life Sciences (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GNWSF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0630.06780.04780.058095212,412-0.013-20.63%
1 Month0.0870.1040.04780.075606431,043-0.037-42.53%
3 Months0.030.11150.02560.065511640,8880.0266.67%
6 Months0.03350.11150.02180.057902834,6620.016549.25%
1 Year0.080.1450.02180.066404730,743-0.03-37.5%
3 Years0.14140.1880.0130.080118229,686-0.0914-64.64%
5 Years0.3060.5270.0080.108177861,955-0.256-83.66%

Stagezero Life Sciences (PK) Description

GeneNews Limited (formerly ChondroGene Limited) is a biotechnology company that is focused on applying the Sentinel PrincipleTM to develop and commercialize novel blood-based molecular diagnostic tests in cancer, cardiovascular disease, central nervous system disorders and arthritis. GeneNews is developing specific diagnostic tests in these areas that address critical unmet clinical need.

Your Recent History
Stagezero ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.